Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
CEO banks on 'lipstick effect' to offset Brexit wobbles
12 Sep 2020
Published by: The Australian Financial Review
Investor Stream chats with: Bod Australia CEO Jo Patterson
07 Jul 2020
Published by: Investor Stream
Bod Australia issues first MediCabilis scripts under Europe’s largest medicinal cannabis project
12 May 2020
Published by: Small Caps
Bod Australia revenue surges 144 per cent
06 Apr 2020
Published by: Business News Australia
Investor Stream chats with: Bod Australia CEO Jo Patterson (March 31, 2020)
31 Mar 2020
Published by: Investor Stream
Bod Australia (ASX:BDA) and Swisse launch hemp product range
30 Mar 2020
Published by: The Market Herald
Revenue doubles, losses halved for Bod Australia
28 Feb 2020
Published by: Business News Australia
Investor Stream chats with: BOD Australia CEO Jo Patterson (February 12, 2020)
12 Feb 2020
Published by: Investor Stream
Cannabis: Bod gets new import clearance from regulators; shares lag
11 Feb 2020
Published by: Stockhead